Improving Blood Pressure Control in Diabetic Patients at High Cardiovascular Risk
Author Information
Author(s): Elliott Henry L., Lloyd Suzanne M., Ford Ian, Meredith Peter A.
Primary Institution: University of Strathclyde, University of Glasgow
Hypothesis
Does the addition of nifedipine GITS improve blood pressure control and outcomes in patients with diabetes and high cardiovascular risk?
Conclusion
The addition of nifedipine GITS significantly improved blood pressure control and outcomes in patients with diabetes at high cardiovascular risk.
Supporting Evidence
- Patients with diabetes had higher rates of all-cause death and major cardiovascular events compared to those without diabetes.
- After 4 years of treatment, 58% of patients with diabetes on nifedipine achieved blood pressure below 140/90 mmHg.
- Significant improvements in blood pressure control were observed with the addition of nifedipine GITS.
Takeaway
This study found that giving a specific blood pressure medicine called nifedipine to people with diabetes helped them control their blood pressure better and feel healthier.
Methodology
This was a posthoc analysis of the ACTION trial, which included 1113 patients with diabetes mellitus who were analyzed for blood pressure control and cardiovascular outcomes.
Potential Biases
The analysis may be subject to biases inherent in retrospective studies.
Limitations
The study is a retrospective analysis with relatively modest statistical power.
Participant Demographics
Approximately 85% of the participants with diabetes were classified as having type 2 diabetes.
Statistical Information
P-Value
p<0.0001
Confidence Interval
95% CI not specified
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website